Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NU vs GSK✓SelectedUSD · GSKNU vs GSK performance historyLatest closeAs of-4.08%11/16
Stock and ETF performance explorer

NU vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-18.7%
GSK return
+9.7%
Excess return
-28.4%
Maximum drawdown
-38.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.1%-0.1%-4.0%-4.1%
7D+2.6%-1.3%+3.9%+2.8%
30D-12.9%+2.7%-15.6%-13.3%
3M-16.7%+2.7%-19.5%-16.8%
6M+4.0%+3.3%+0.7%+3.3%
YTD-24.3%+6.5%-30.7%-22.1%
All-18.7%+9.7%-28.4%-17.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling